GlassScriptPhysician profile
Michael S Vance
NPI 1932141058
$53,094.22
in general payments reported to CMS, 2019-2025
7 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $81.96 · 2021: $1,466 · 2022: $1,644 · 2023: $3,594 · 2024: $1,631 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,329 · Food and Beverage: $2,015 · Education: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,329.10 |
| Food and Beverage | $2,014.54 |
| Education | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $44,100.55 | 2019-2021 | |
| Medtronic, INC. | $7,342.02 | 2021-2025 | Harmony |
| Medtronic Vascular, INC. | $1,356.60 | 2019-2020 | |
| Edwards Lifesciences Corporation | $117.70 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $113.69 | 2024 | Gore Cardioform Septal Occluder |
| B. Braun Interventional Systems INC. | $39.14 | 2025 | Cp Stent |
| Biosense Webster, INC. | $24.52 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.